Tazorac
- Product NDC
- 16110-042
- 11-digit product format
- 161100042
- Labeler code
- 16110
- Product ID
- 16110-042_7e6df473-8f69-4d67-bd06-a24f35ab0a62
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tazarotene
- Dosage form
- GEL
- Route
- CUTANEOUS
- Labeler
- Almirall, LLC
- Application
- NDA020600
- Marketing category
- NDA
- Marketing start
- 2020-02-21
- Substance
- TAZAROTENE
- Active strength
- 1 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tazorac
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TAZAROTENE | 1 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 81BDR9Y8PS |
| Rxcui | 212437, 212438, 313199, 313201 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16110-042 | TAZORAC (TAZAROTENE) GEL [ALMIRALL, LLC] | 2 | Current NDC, Legacy NDC, 4 package rows | 20240821_4e4e4b81-420e-4492-8a74-80b692a80057.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16110-042-10 | 16110004210 | 1 TUBE in 1 CARTON (16110-042-10) / 100 g in 1 TUBE | 1 tube | 2020-02-21 | 0000-00-00 | No | No | Current |
| 16110-042-30 | 16110004230 | 1 TUBE in 1 CARTON (16110-042-30) / 30 g in 1 TUBE | 1 tube | 2020-02-21 | 0000-00-00 | No | No | Current |